BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 2007

View Archived Issues

Recent patents disclose novel analgesic agents

Read More

New treatment strategy for microbial infections claimed in recent Novozymes patent

Read More

Recent Asahi Kasei patent reports novel agents for treating glaucoma

Read More

MediGene and JDRF collaborate on mTCR therapeutics for type 1 diabetes

Read More

Novel glucocorticoid receptor agonist shows in vivo efficacy and improved safety profile

Read More

DELTA MI trial shows beneficial effects of KAI-9803 in myocardial infarction

Read More

Synergy seen with verotoxin-1 and monophosphoryl lipid A in mouse fibrosarcoma

Read More

Garenoxacin effective for Streptococcus pneumoniae respiratory tract infections

Read More

New data on hepatitis C treatments including pegylated interferon reported

Read More

Viral kinetics, mechanism of action of DEBIO-025 explored

Read More

[N-MeIle4]-cyclosporin and NM-107 exert synergistic anti-HCV activity in vitro

Read More

Pilot bioavailability study for immediate release CDT-fenofibrate tablets

Read More

FDA extends review period for Torisel NDA

Read More

Inhibitex to acquire FermaVir

Read More

MAESTRO-01 trial of MBP-8298 cleared to continue

Read More

ACR-16 studied in new phase Ib trial for schizophrenia

Read More

Enrollment completed in phase III trials of PF-3512676 for NSCLC

Read More

Renovis and Pfizer extend VR1 research collaboration

Read More

Dosing begins in phase I study of AC-220 for AML

Read More

Roche and Transgene establish HPV collaboration

Read More

Reolysin studied in phase II trial for metastatic sarcomas

Read More

Pancreatic cancer study of Erbitux plus gemcitabine misses endpoint

Read More

Swiss approval for phase III trial of CUV-1647 for erythropoietic protoporphyria

Read More

ARRY-797 to be studied in cancer patients

Read More

Protemix raises funds to advance pipeline

Read More

Imbalance in cardiovascular and neoplasm SAEs in alvimopan trial

Read More

PS-433540 well tolerated and potentially suited for once-daily administration

Read More

Follistim introduced in Japan for induction of ovulation in infertile women

Read More

Brovana available in U.S.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing